Homeland Security, Defense and Human Effects Experts Appointed to Harrington Advisory Board

Share Article

MDM Group, Inc. announced that MDM Group subsidiary, Harrington Group Limited earlier today advised the Australian Stock Exchange of the appointment of an additional three world-renowned homeland security experts as founding members of the Harrington Group Advisory Board.

MDM Group, Inc. (OTC.PK: MDDM) advises that MDM Group subsidiary, Harrington Group Limited (HGR.AX) earlier today advised the Australian Stock Exchange of the appointment of an additional three world-renowned homeland security experts as founding members of the Harrington Group Advisory Board.

Joining Colonel John Alexander, a global authority on non-lethal weapons and defense, will be Dr. Christopher Green, a forensic medicine and electrophysiology specialist, Dr. Edward Stephen, a specialist in pharmacology and bioterrorism defense, and Dr. Allen Bain, a leading pharmacologist focused on specialised drug development including new treatments for disorders of electrically active tissue.

The combined expertise of the Advisory Board will provide Harrington with outstanding guidance in strategic product development and commercialisation, and grow the Company's profile in the law enforcement, defense and homeland security sectors.

Harrington Group CEO Marshall Couper said: "All four Advisory Board members have extensive knowledge of Harrington's ShockRounds(TM) electric ammunition technology, as well as outstanding expertise in less-than-lethal weapons, Homeland Security issues and human effects.

"Harrington is focused on accelerating its product development, formalising strategic and commercial relationships and securing the expertise of leaders in the field. The formation of a world class Advisory Board is an important step forward in this strategy."

Joining Colonel Alexander are:

Christopher C. Green, MD, PhD, FAAFS

Dr. Green is in the practice of forensic medicine (American Academy of Forensic Sciences) and neuroimaging (Detroit Medical Center/Harper University Hospital/Wayne School of Medicine). His work clinically relates to his expertise as a neurophysiologist with a specialty in electrophysiology. A special research interest involves the way cognition in "making decisions under stress" are modulated by brain systems and neuromuscular control. He is both a faculty member at the Medical School and Fellow in Diagnostic Radiology, and Executive Director for Emergent Technologies.

Dr. Green serves on numerous Department of Defense, Intelligence and National Academy of Sciences Commissions. He Chairs the Science Board for the Undersecretary of the Army for Operations Research and has served as Chair of the Board on Army Science and Technology. He holds the National Intelligence Medal for investigations in forensic intelligence and served as an Officer and continues as a consultant with the Central Intelligence Agency.

Edward L. Stephen, DVM

Dr. Edward L. Stephen is a specialist in bioterrorism and biodefense and in this field also heads up the biodefense division of MDM Group, Inc (MDDM).

His initial working assignment was at Ft. Detrick where, in the Special Operations Division, he played key roles in bioterrorism defense including assessment of vulnerability of limited targets such as the New York subway system and the Pentagon. Further, he was involved in the R&D of a range of weapons and helped to test and evaluate various kinds of drugs, chemicals, and toxins as they might relate to capture or restraint.

Most recently and for the past five (5) years, Dr. Stephen has been a Senior Project Manager at the International Science and Technology Center (ISTC; http://www.istc.ru). In this role, he has been evaluating the scientific experience and expertise of scientists and support personnel involved in the R&D of biological weapons of mass destruction (BioWMD). He has reviewed the credentials and publications of scientists and support personnel of literally thousands of individuals as the initial step of integrating this experience and expertise into collaborative bio-defense research projects between the governments of Russia and the US. During future visits to Russia, he will be discussing the current and future R&D needs of the Harrington Group with various organisations.

Allen I Bain, PhD

Dr. Bain is a pharmacologist focused on new drug development including, treatments for disorders of the brain, heart and other electrically active tissue. As a co-founder, officer, or director of several companies spanning nearly two decades, Dr. Bain has participated in leadership roles in both the business and the science of drug discovery. Most notably, Dr. Bain co-founded Cardiome Pharma, whose flagship ion channel modulating drug to treat cardiac arrhythmias is in Phase 3 clinical trials in the U.S., supported by a large pharmaceutical company. Until recently, Dr. Bain was an honorary lecturer at the Department of Pharmacology and Therapeutics at the University of British Columbia, where he was awarded his doctorate in pharmacology in 1994 for his work in neuroscience.

Harrington Group is a developer of Homeland Security and Law Enforcement products and solutions including ShockRounds(TM) -- positioned as a major breakthrough in the ammunition, military and law enforcement industries. See: http://www.hgrltd.com

MDM Group is a development stage research and development Company focused on the Security, Biodefense and Homeland Defense industries See: http://www.mdmgroupinc.com

ShockRounds(TM) introduces an electric charge to traditional ammunition and other projectiles such as rubber bullets through the combination of existing ballistic and piezoelectric technologies. See: http://www.shockrounds.com

Safe Harbor Statement

The information in this release, other than historical information, may be considered forward-looking statements within the provisions of the Private Securities Litigation Reform Act of 1995. Projection and other forward-looking statements and management expectations regarding future events and/or financial performance of the Company -- although given in good faith -- are inherently uncertain and actual events and/or results may differ materially.

SOURCE: MDM Group, Inc

For further information see: http://www.shockrounds.com - http://www.hgrltd.com and http://www.mdmgroupinc.com

MDM Group is featured on http://www.Homelanddefensestocks.com, a global investment research portal for defense and security.

For full details: http://www.investorideas.com/Companies/MDMGroup/NewsReleases.asp


MDM Group Inc

Trevor Ruehs



Share article on social media or email:

View article via:

Pdf Print

Contact Author

Trevor Ruehs